Clinical Trial

CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery

Study acronym: CORA-Q15
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of the study will be to compare the efficacy of single-injection interscalene block versus continuous interscalene block on the quality of recovery in patients undergoing outpatient arthroscopic rotator cuff repair surgery. The participants will: * Be randomized to receive either a single-injection interscalene block or continuous infusion via an elastomeric pump. * Be monitored via telephone by the research team to complete the QoR-15 survey, assess pain levels, the need for tramadol use, and any complications. * Have follow-up by the Acute Pain Unit during the first 3 days.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-23; most recent amendment 2025-05-26.
Status change: Not Yet Recruiting → Recruiting 2025-05-26
Trial Details
NCT Number NCT06754657
Lead Sponsor Pontificia Universidad Catolica de Chile
Conditions Arthropathy Shoulder, Pain, Acute, Anesthesia
Enrollment 150 participants
Start Date 2025-05-26
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-30